Antiplatelet therapy to prevent hemodialysis vascular access failure: systematic review and meta-analysis.
暂无分享,去创建一个
A. Webster | M. Jardine | J. Craig | V. Perkovic | G. Tognoni | P. Ravani | S. Palmer | G. Strippoli | A. Nicolucci | F. Pellegrini | G. Graziano | L. Di Micco | M. Razavian
[1] A. Da Silva,et al. Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts. , 2015, The Cochrane database of systematic reviews.
[2] M. Tonelli,et al. Effect of fish oil supplementation on graft patency and cardiovascular events among patients with new synthetic arteriovenous hemodialysis grafts: a randomized controlled trial. , 2012, JAMA.
[3] G. Beck,et al. Use of aspirin associates with longer primary patency of hemodialysis grafts. , 2011, Journal of the American Society of Nephrology : JASN.
[4] C. White,et al. Antiplatelet agents for the prevention of arteriovenous fistula and graft thrombosis: a meta analysis , 2010, International journal of clinical practice.
[5] G. Beck,et al. Effect of dipyridamole plus aspirin on hemodialysis graft patency. , 2009, The New England journal of medicine.
[6] D. Moher,et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement , 2009, BMJ : British Medical Journal.
[7] A. Ehsanpour,et al. Randomized controlled trial of clopidogrel to prevent primary arteriovenous fistula failure in hemodialysis patients , 2009, Indian journal of nephrology.
[8] Stephane Heritier,et al. Preventing AVF thrombosis: the rationale and design of the Omega-3 fatty acids (Fish Oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study , 2009, BMC nephrology.
[9] G. Beck,et al. Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial. , 2008, JAMA.
[10] I. Abdul-Rahman,et al. Warfarin Versus Aspirin in Preventing Tunneled Hemodialysis Catheter Thrombosis: A Prospective Randomized Study , 2007 .
[11] Simona Gioberge,et al. ESRD patients in 2004: global overview of patient numbers, treatment modalities and associated trends. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[12] E. Ritz,et al. Prevention of p.o. clotting of av. cimino fistulae with Acetylsalicyl acid results of a prospective double blind study , 1974, Klinische Wochenschrift.
[13] T. Stijnen,et al. Radiocephalic wrist arteriovenous fistula for hemodialysis: meta-analysis indicates a high primary failure rate. , 2004, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.
[14] J. Hux,et al. Late creation of vascular access for hemodialysis and increased risk of sepsis. , 2004, Journal of the American Society of Nephrology : JASN.
[15] D. Altman,et al. Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.
[16] P. Peduzzi,et al. Randomized controlled trial of clopidogrel plus aspirin to prevent hemodialysis access graft thrombosis. , 2003, Journal of the American Society of Nephrology : JASN.
[17] M. Robbin,et al. Increasing arteriovenous fistulas in hemodialysis patients: problems and solutions. , 2002, Kidney international.
[18] A. Mattioli,et al. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.
[19] Catherine Sudlow,et al. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.
[20] H. Mulec,et al. Effects of ticlopidine in AV-fistula surgery in uremia. Fistula Study Group. , 1998, Scandinavian journal of urology and nephrology.
[21] J. Himmelfarb,et al. Anti-platelet therapy in graft thrombosis: results of a prospective, randomized, double-blind study. , 1994, Kidney international.
[22] J. Marx,et al. Low-dose aspirin does not prevent thrombovascular accidents in low-risk haemodialysis patients during treatment with recombinant human erythropoietin. , 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[23] C. Fiskerstrand,et al. Double-blind randomized trial of the effect of ticlopidine in arteriovenous fistulas for hemodialysis. , 1985, Artificial organs.
[24] H. Mulec,et al. Thromboprophylactic effect of ticlopidine in arteriovenous fistulas for haemodialysis. , 1985, Scandinavian journal of urology and nephrology.
[25] S. Koshikawa,et al. Antithrombotic therapy with ticlopidine in chronic renal failure patients on maintenance hemodialysis--a multicenter collaborative double blind study. , 1980, Thrombosis research.
[26] P. Majerus,et al. Prevention of thrombosis in patients on hemodialysis by low-dose aspirin. , 1979, The New England journal of medicine.
[27] J. Hirsh,et al. Arteriovenous-shunt thrombosis. Prevention by sulfinpyrazone. , 1974, The New England journal of medicine.